logo
Share SHARE
FONT-SIZE Plus   Neg

Delcath Systems' Hepatic CHEMOSAT Delivery System Used First To Treat Patient

Specialty pharmaceutical company Delcath Systems Inc (DCTH) Friday revealed that the European Institute of Oncology, a premier cancer treatment and research center in Milan has performed the first treatment using the second generation hemofiltration cartridge of the Company's proprietary Hepatic CHEMOSAT Delivery System.

The company stated that a patient was treated for inoperable liver-dominant metastases from ocular melanoma, a case that represents the first use of the second generation hemofiltration cartridge in a clinical setting.

"We are pleased to finally be able to provide the second generation CHEMOSAT system to our early launch centers in Europe," said Eamonn P. Hobbs, President and CEO of Delcath Systems. "Now that we are beginning to treat patients with the new system, we are confident that efficiency data we've seen in our in vivo studies will be validated in actual clinical use. We are also pleased that the team at the IEO is the first to begin exploring the benefits of the new system, and look forward to working with them and other early launch centers to establish the benefits of this system for patients with cancers in the liver."

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Philip Morris International Inc. has filed an application with the U.S. Food and Drug Administration to market a new type of cigarette that holds potentially less health risks than conventional cigarettes. The new type of cigarette electronically heats tobacco to produce a vapor without burning it, making it less harmful. Apple Inc. has confirmed that the iPhone 6s battery issue may be larger than thought, as the tech giant said that some customers "outside the affected range of devices" have also reported unexpected shutdowns. The company again stressed that it is not a security issue. Tesla Motors Inc. voluntarily recalled more than 7000 charging adapters. The company said these adapters of Nema 14-30, 10-30 and 6-50 are sold separately as accessories. Earlier in November, two customers had complained about overheating issue of Nema 14-30 charging adapters. Tesla confirmed in its recall communication that there were no other similar incidents or reports of injuries or proper
comments powered by Disqus
Follow RTT